R. Kotlín

发表

The Effect of Reagents Mimicking Oxidative Stress on Fibrinogen Function

K. Pimková, J. Dyr, T. Riedel, 2013, TheScientificWorldJournal.

Incorporation of Fibrin, Platelets, and Red Blood Cells into a Coronary Thrombus in Time and Space

J. Weisel, J. Dyr, T. Riedel, 2021, Thrombosis and Haemostasis.

Two novel mutations in the fibrinogen γ nodule.

P. Salaj, J. Dyr, T. Riedel, 2014, Thrombosis research.

A novel natural mutation AαPhe98Ile in the fibrinogen coiled-coil affects fibrinogen function

P. Májek, J. Dyr, T. Riedel, 2013, Thrombosis and Haemostasis.

Two novel fibrinogen variants in the C-terminus of the Bβ-chain: fibrinogen Rokycany and fibrinogen Znojmo

J. Kvasnička, P. Salaj, J. Dyr, 2010, Journal of Thrombosis and Thrombolysis.

A New Approach for the Diagnosis of Myelodysplastic Syndrome Subtypes Based on Protein Interaction Analysis

J. Homola, N. Lynn, M. Hubálek, 2019, Scientific Reports.

Enhanced plasma protein carbonylation in patients with myelodysplastic syndromes

J. Čermák, P. Májek, J. Dyr, 2017, Free radical biology & medicine.

Proteomic analysis of plasma samples from acute coronary syndrome patients - the pilot study.

J. Veselka, P. Májek, J. Dyr, 2012, International journal of cardiology.

Plasma Levels of Aminothiols, Nitrite, Nitrate, and Malondialdehyde in Myelodysplastic Syndromes in the Context of Clinical Outcomes and as a Consequence of Iron Overload

J. Čermák, J. Dyr, Jana Štikarová, 2014, Oxidative medicine and cellular longevity.

Antioxidants change platelet responses to various stimulating events.

J. Weisel, P. Májek, J. Dyr, 2009, Free radical biology & medicine.

Abnormal Fibrinogen Zlín (γThr21Ile) with Missense Mutation Causing Hypofibrinogenemia

P. Májek, J. Dyr, T. Riedel, 2014, Acta Haematologica.

Fibrinogen Šumperk II: Dysfibrinogenemia in an individual with two coding mutations

J. Dyr, R. Kotlín, J. Suttnar, 2012, American journal of hematology.

Two cases of congenital dysfibrinogenemia associated with thrombosis – Fibrinogen Praha III and Fibrinogen Plzeň

P. Salaj, J. Dyr, T. Riedel, 2009, Thrombosis and Haemostasis.

Thrombosis-associated hypofibrinogenemia: novel abnormal fibrinogen variant FGG c.8G>A with oxidative posttranslational modifications

J. Dyr, Jana Štikarová, R. Kotlín, 2022, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Fibrinogen Nový Jičín and Praha II: Cases of hereditary Aα 16 Arg→Cys and Aα 16 Arg→His dysfibrinogenemia

J. Blatny, P. Salaj, J. Šantrůček, 2007 .

Clinical manifestation and molecular genetic characterization of MYH9 disorders

D. Mikulenková, R. Kotlín, V. Maťoška, 2009, Platelets.

Protein Carbonylation in Patients with Myelodysplastic Syndromes

J. Čermák, P. Májek, J. Dyr, 2015 .

Congenital dysfibrinogenemia Aα Gly13Glu associated with bleeding during pregnancy.

P. Salaj, J. Dyr, R. Kotlín, 2011, Thrombosis research.

High-resolution melting analysis for detection of MYH9 mutations

P. Salaj, R. Kotlín, V. Maťoška, 2008, Platelets.

Acquired Dysfibrinogenemia Secondary to Multiple Myeloma

P. Salaj, P. Májek, J. Dyr, 2008, Acta Haematologica.

Structural and Functional Characterization of Four Novel Fibrinogen Mutations in FGB Causing Congenital Fibrinogen Disorder

Ž. Sovová, Jana Štikarová, R. Kotlín, 2022, International journal of molecular sciences.

Three cases of abnormal fibrinogens: Šumperk (Bβ His67Leu), Uniãov (Bβ Gly414Ser), and Brno (γArg275His)

D. Pospíšilová, P. Smejkal, P. Salaj, 2008, Thrombosis and Haemostasis.

A novel fibrinogen variant – Praha I: hypofibrinogenemia associated with γ Gly351Ser substitution

P. Salaj, J. Šantrůček, J. Dyr, 2007 .

Alteration of Serum Malondialdehyde Level As Biomarker of Oxidative Stress during Acute Myeloid Leukemia Treatment

J. Dyr, Jana Štikarová, R. Kotlín, 2019, Blood.

Diagnosing Czech Patients with Inherited Platelet Disorders

P. Salaj, Jana Štikarová, R. Kotlín, 2022, International journal of molecular sciences.

Hsp70 Trap Assay for Detection of Misfolded Subproteome Related to Myelodysplastic Syndromes.

J. Homola, J. Čermák, J. Dyr, 2019, Analytical chemistry.

A novel fibrinogen variant – Liberec: dysfibrinogenaemia associated with γ Tyr262Cys substitution

P. Salaj, J. Dyr, T. Riedel, 2008, European journal of haematology.

Targeted Metabolomic Profiling in Acute Myeloid Leukemia with IDH2R140 and IDH2R172 Mutations

J. Dyr, Jana Štikarová, R. Kotlín, 2018, Blood.

CCAAT/enhancer-binding protein alpha (CEBPA) polymorphisms and mutations in healthy individuals and in patients with peripheral artery disease, ischaemic heart disease and hyperlipidaemia.

M. Zeman, R. Kotlín, G. Dostálová, 2010, Folia biologica.

Linking aberrant glycosylation of plasma glycoproteins with progression of myelodysplastic syndromes: a study based on plasmonic biosensor and lectin array

J. Homola, M. Havlíček, Jana Štikarová, 2023, Scientific Reports.

Nature of frequent deletions in CEBPA.

M. Kouba, J. Březinová, J. Čermák, 2009, Blood cells, molecules & diseases.